AGH Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$490K Sell
997
-35
-3% -$19K 0.36% 59
2025
Q4
$598K Sell
1,032
-6
-0.6% -$3.39K 0.45% 44
2025
Q3
$503K Buy
1,038
+186
+22% +$86.6K 0.37% 58
2025
Q2
$345K Sell
852
-134
-14% -$56K 0.28% 73
2025
Q1
$491K Sell
986
-132
-12% -$71.5K 0.47% 45
2024
Q4
$582K Buy
+1,118
New +$615K 0.54% 40

Other funds holding TMO

AGH Wealth Advisors's TMO Position: Q1 2026 in Review

AGH Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 3.4% in Q1 2026, selling an estimated $19K and leaving 997 shares worth $490K. The position accounts for 0.36% of the portfolio, ranked #59.

AGH Wealth Advisors first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $598K in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • AGH Wealth Advisors held 997 shares of Thermo Fisher Scientific worth $490K as of Q1 2026.
  • AGH Wealth Advisors sold 35 Thermo Fisher Scientific shares in Q1 2026, an estimated $19K.
  • Thermo Fisher Scientific made up 0.36% of AGH Wealth Advisors's portfolio in Q1 2026, its #59 holding.
  • AGH Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • AGH Wealth Advisors's Thermo Fisher Scientific position peaked at $598K in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on AGH Wealth Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.